Prognostic risk factors in low stage testicular germ cell tumors
Open Access
- 1 May 1997
- Vol. 79 (9) , 1641-1645
- https://doi.org/10.1002/(sici)1097-0142(19970501)79:9<1641::aid-cncr1>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- MIB-1 immunohistochemistry in clinical Stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasisCancer, 1997
- Improved Accuracy of Computerized Tomography Based Clinical Staging in Low Stage Nonseminomatous Germ Cell Cancer Using Size Criteria of Retroperitoneal Lymph NodesJournal of Urology, 1995
- Proliferating Cell Nuclear Antigen Expression to Predict Occult Disease in Clinical Stage I Nonseminomatous Testicular Germ Cell TumorsJournal of Urology, 1994
- Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: A wager on the future? A reviewEuropean Journal Of Cancer, 1993
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- Surveillance for Clinical Stage I Nonseminomatous Testis Carcinoma: Rationale and ResultsUrologia Internationalis, 1991
- Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.Journal of Clinical Oncology, 1990
- Immunohistological determination of proliferative activity in seminomas.Journal of Clinical Pathology, 1988
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982